Plastic-scintillator based PET detector for proton beam therapy range monitoring : preliminary study by Ruciński, A. et al.
S246   ESTRO 38 
PV-0480  Plastic-scintillator based PET detector for 
proton beam therapy range monitoring: preliminary 
study 
A. Rucinski1, J. Baran1, M. Garbacz1, M. Pawlik-
Niedzwiecka1, P. Moskal2 
1Institute of Nuclear Physics PAN, Proton Radiotherapy 
Group, Krakow, Poland ; 2Jagiellonian University, 
Faculty of Physics- Astronomy and Applied Computer 
Science, Krakow, Poland  
Purpose or Objective 
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clinic. In PBT the distribution of beta+ emitters induced 
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traces using tracking, while dropping below 50% when the
tracking system was deactivated.
Conclusion
The new ADAM’s tool demonstrates suitable performances
to test, in realistic patient-like conditions, tracking
systems based on soft tissue detection.
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Purpose or Objective
The aim of the study is the further development of an
anthropomorphic multimodality pelvis phantom (ADAM,
[1]) for the integration of PSMA-PET/MRI-based treatment
planning of prostate cancer patients.
Material and Methods
CT and 3T-MRI characteristics of different tissue types are
mimicked using agarose gels (Agarose NEEO Ultra-Qualität
Carl Roth GmbH + Co. KG, Germany) mixed with different
concentrations of Gadolinium (Gd, MultiHance® 0.5 M,
Bracco Imaging Deutschland GmbH) and sodium fluoride
(NaF, Carl Roth GmbH + Co. KG). Gels were scanned using
a 3T PET/MRI (Biograph mMR, Siemens Healthineers,
Erlangen, Germany) using a saturation recovery sequence
with multiple inversion times and a spin-echo sequence
with multiple echo times. Based on the resulting images,
T1- and T2-relaxation times were determined using in-
house written software. CT scans of the agarose mixtures 
were performed on a stand-alone CT scanner (Somatom
Definition Flash, Siemens Healthineers) at 120 kV and 390
mAs.
Agarose mixtures that agreed best with reference values
derived from literature data [2-4] were subsequently
doped with patient-specific activity concentrations of 18F
and 68Ga (e.g. 3 kBq/ml 68Ga and 11 kBq/ml 18F for the
primary tumor). Organ shells (prostate with two
intraprostatic lesions, lymph nodes and bone metastases)
were printed using a 3D printer (Stratasys Objet 300
Connex 3, print material: VeroClear). The doped, liquid
agarose gels were filled into the organ shells where they
solidified within seconds. Organ shells were scanned at the
3T PET/MRI scanner (PET acquisition time: 10 min, MRI:
T2-weighted morphological sequence).
Results
The final compositions of agarose gels are the following
(given as mass fractions of agarose/NaF/Gd): Prostate
(1.35%/3.2%/0.011%), lesions (2.25%/3.2%/0.0085%) and
lymph nodes (3.2%/1.4%/0.025%).
T1- and T2-relaxation times and CT numbers of the
developed agarose gels fit well to reference values (Figure
1). Exemplary PET- and MR-images of a prostate with two
intraprostatic lesions doped with 11 kBq/mL 18F are shown
in Figure 2. The PET signal can be detected and the tumors
appear hypointense on T2-weighted MRI.
Conclusion
Agarose gel mixtures with organ-specific MR-relaxation
times at 3T and CT numbers have been developed and
doped with radioactive tracers. The gels will be used in
the pelvis phantom which will be central to simulate and
optimize the technical workflow for the integration of
PSMA-PET/MRI-based RT planning of prostate cancer
patients.
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by a proton beam in a patient can be detected by PET 
scanners, the emission distribution can be reconstructed 
and used for monitoring of the beam range. A prototype 
of a diagnostic strip-based whole-body PET scanner (J-
PET) has been developed and tested at the Jagiellonian 
University in Krakow (Moskal et al. Phys. Med. Biol. 61 
(2016) 2025-2047). The advantages of the system over 
commercial PET scanners is that it increases the 
geometrical acceptance and facilitates integration in the 
treatment room, off-line or in the treatment position. The 
aim of this work is to study a feasibility of the J-PET 
technology for range verification in PBT. 
Material and Methods 
A single detection module of the strip-PET scanner is 
constructed out of thirteen 50-cm long organic scintillator 
strips. The light pulses produced in a strip by gamma 
quanta are propagated to its edges and converted into 
electrical signals by silicon photomultipliers (see Fig. 1). 
They are read-out by fast on-board front-end electronics 
allowing excellent overall coincidence resolving time 
(CRT) of about 300 ps, which shows a significant 
improvement compared to the standard LSO-based PET 
scanners. Three different configurations of the modular 
system were investigated: (i) a single layer consisting of 
24 modules, (ii) a two-layer consisting of 20 and 24 
modules, and (iii) three-layer consisting of 20, 24 and 28 
modules.  GATE Monte Carlo (MC) toolkit has been used to 
investigate the modular JPET system efficiency for 
detection of beta+ annihilation back to back photons 
induced in PMMA target by a proton beam (see Fig. 2). A 
MC based comparison of a J-PET based dual head system 
consisting of 2x5 modules configured as two opposing 
heads with the clinically operated inter-spill dual-head 
PET system installed at CNAO (V. Ferrero et al. Sci. Rep. 




The efficiency of the system in the proton beam 
simulation increases quadratically with the number of 
detector layers. It ranges from 0.12% for single layer setup 
to 0.75% for three-layer setup. Detected coincidences per 
primary proton for the single layer, two and three layer 
modular JPET configurations is 4.0*10^(-5), 1.3*10^(-4) 
and 2.5*10^(-4), respectively. The comparison of the dual 
head JPET and PET system installed at CNAO reveals 
comparable results.  
Conclusion 
Performed simulations suggest the signal obtained with 
the J-PET detector technology during proton beam 
therapy is sufficient for range monitoring. The results 
revealed that inter-spill beam range monitoring is 
achievable with both, dual-head and multi-layer JPET 
configurations. Experimental verification of the 
performed simulations is planned. 
